Literature DB >> 10606187

Prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma.

M C Uygur1, A Usubütün, H Ozen, A Ayhan, S Kendi.   

Abstract

The objective of this study is to evaluate the prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma. We reviewed 62 cases of metastatic renal cell carcinoma to document the factors influencing survival and to evaluate the role of nephrectomy. Sex and age of patients, size of primary tumor, site and number of metastases, nephrectomy, cell type and grade of tumor and medical treatment were analyzed as prognostic factors. Age and sex, cell type and type of medical treatment cannot be considered reliable predicting factors. However, improved survival was correlated with tumor size < or = 7 cm in diameter, low grade histology, metastasis limited to single organ and removal of the primary tumor. When these parameters were analyzed in a multivariate model, the presence of nephrectomy was the sole significant parameter. We therefore suggest that nephrectomy should be considered in all patients with metastatic renal cell carcinoma, as long as the morbidity of the operation is acceptable.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10606187

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  5 in total

Review 1.  Current Management Strategy for Metastatic Renal Cell Carcinoma and Future Directions.

Authors:  Hussein Merza; Marijo Bilusic
Journal:  Curr Oncol Rep       Date:  2017-04       Impact factor: 5.075

2.  Over-expression of DNA-PKcs in renal cell carcinoma regulates mTORC2 activation, HIF-2α expression and cell proliferation.

Authors:  Bing Zheng; Jia-Hui Mao; Xiao-Qing Li; Lin Qian; Hua Zhu; Dong-Hua Gu; Xiao-Dong Pan
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

3.  Dual inhibition of BRD4 and PI3K-AKT by SF2523 suppresses human renal cell carcinoma cell growth.

Authors:  Hua Zhu; Jia-Hui Mao; Yin Wang; Dong-Hua Gu; Xiao-Dong Pan; Yuxi Shan; Bing Zheng
Journal:  Oncotarget       Date:  2017-09-30

4.  microRNA-302c-3p inhibits renal cell carcinoma cell proliferation by targeting Grb2-associated binding 2 (Gab2).

Authors:  Dong-Hua Gu; Jia-Hui Mao; Xiao-Dong Pan; Hua Zhu; Xinfeng Chen; Bing Zheng; Yuxi Shan
Journal:  Oncotarget       Date:  2017-04-18

5.  Concurrent inhibition of mTORC1 and mTORC2 by WYE-687 inhibits renal cell carcinoma cell growth in vitro and in vivo.

Authors:  Xiao-Dong Pan; Dong-Hua Gu; Jia-Hui Mao; Hua Zhu; Xinfeng Chen; Bing Zheng; Yuxi Shan
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.